東陽光藥：中期報告2021.pdf

《東陽光藥：中期報告2021.pdf》由会员分享，可在线阅读，更多相关《東陽光藥：中期報告2021.pdf（134页珍藏版）》请在三个皮匠报告上搜索。

1、CONTENTS目錄2Financial Highlights財務摘要3Corporate Profile公司簡介6Management Discussion and Analysis管理層討論及分析81Corporate Governance and Other Information企業管治及其他資料90Review Report審閱報告92Consolidated Statement of Profit or Loss and Other Comprehensive Income綜合損益及其他全面收益表93Consolidated Statement of Financial Posit

2、ion綜合財務狀況表95Consolidated Statement of Changes in Equity綜合權益變動表97Condensed Consolidated Cash Flow Statement簡明綜合現金流量表98Notes to the Unaudited Interim Financial Reports未經審核中期財務報告附註129Corporate Information公司資料YICHANG HEC CHANGJIANG PHARMACEUTICAL CO.,LTD./INTERIM REPORT 20212Financial Highlights財務摘要(RMB

3、000)（人民幣千元）Six months ended 30 June 2021截至二零二一年六月三十日止六個月Six months ended 30 June 2020截至二零二零年六月三十日止六個月Year ended 31 December截至十二月三十一日止年度 2020201920182017二零二零年二零一九年二零一八年二零一七年 Revenue營業額202,2462,083,7052,348,1136,224,024 2,510,4761,601,567Gross profit毛利100,7881,730,8411,996,5665,302,202 2,111,6671,321,

4、151(Loss)/profit from operations經營（虧損）溢利(468,906)880,9001,254,6402,473,556 1,103,742752,484(Loss)/profit before taxation除稅前（虧損）溢利(588,204)757,8361,010,4342,269,053 1,102,324748,195(Loss)/profit attributable to equity shareholders of the Company本公司權益股東 應佔（虧損）溢利(507,028)617,508839,4551,918,709 942,536

5、647,101(Losses)/earnings per share (RMB cent)每股（虧損）盈利（人民幣分）Basic*基本*(58)709521610472 Diluted*攤薄*(31)635320710472Total assets總資產8,913,67310,460,0059,561,2679,912,3394,560,9403,775,975Total liabilities總負債4,316,9915,486,1334,457,6085,289,184882,012715,389Net assets淨資產4,596,6824,973,8725,103,6594,623,15

6、53,678,9283,060,586Profitability盈利能力Gross profit margin毛利率49.8%83.1%85.0%85.2%84.1%82.5%Operating profit margin經營溢利率-231.9%42.3%53.4%39.7%50.4%47.0%Net profit margin淨利潤率-250.7%29.6%35.7%30.6%35.9%39.1%*Adjusted for the bonus issue effected in 2020.*就於二零二零年生效的紅股發行作出調整。3Corporate Profile公司簡介中期報告2021 /